173 related articles for article (PubMed ID: 2445433)
1. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
Hall ME; Grantham P; Limoli J; Stewart JM
Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
[TBL] [Abstract][Full Text] [Related]
2. Behavioural effects of tachykinins and related peptides.
Elliott PJ; Iversen SD
Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
[TBL] [Abstract][Full Text] [Related]
3. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
4. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
[TBL] [Abstract][Full Text] [Related]
5. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
Mathison R; Solomos D
Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
[TBL] [Abstract][Full Text] [Related]
6. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney.
Chen Y; Hoover DB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1176-80. PubMed ID: 7505328
[TBL] [Abstract][Full Text] [Related]
8. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice.
Ravard S; Betschart J; Fardin V; Flamand O; Blanchard JC
Brain Res; 1994 Jul; 651(1-2):199-208. PubMed ID: 7522932
[TBL] [Abstract][Full Text] [Related]
9. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
10. Tachykinin-like central activity of neuromedin K in mice.
Vaught JL; Post LJ; Jacoby HI; Wright D
Eur J Pharmacol; 1984 Aug; 103(3-4):355-7. PubMed ID: 6208040
[TBL] [Abstract][Full Text] [Related]
11. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
Burcher E; Buck SH; Lovenberg W; O'Donohue TL
J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
[TBL] [Abstract][Full Text] [Related]
12. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
Bailey SJ; Lippe IT; Holzer P
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
[TBL] [Abstract][Full Text] [Related]
13. Chemoreceptor responses to substance P, physalaemin and eledoisin: evidence for neurokinin-1 receptors in the cat carotid body.
Prabhakar NR; Kou YuR ; Runold M
Neurosci Lett; 1990 Dec; 120(2):183-6. PubMed ID: 1705679
[TBL] [Abstract][Full Text] [Related]
14. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
15. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release.
Hall ME; Stewart JM
Pharmacol Biochem Behav; 1992 Jan; 41(1):75-8. PubMed ID: 1371611
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and Met-enkephalin releasing effects of tachykinins and substance P fragments.
Naranjo JR; Arnedo A; De Felipe MC; Del Rio J
Peptides; 1986; 7(3):419-23. PubMed ID: 2430264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.
Hua X; Lundberg JM; Theodorsson-Norheim E; Brodin E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):196-201. PubMed ID: 6084817
[TBL] [Abstract][Full Text] [Related]
18. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
Johansson A; Liu L; Holmgren S; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
[TBL] [Abstract][Full Text] [Related]
19. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection.
Kuwahara H; Sakurada T; Sakurada S; Yonezawa A; Ando R; Kisara K; Osakada F; Munekata E
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):656-60. PubMed ID: 2451137
[TBL] [Abstract][Full Text] [Related]
20. Opioid and neurokinin activities of substance P fragments and their analogs.
Lei SZ; Lipkowski AW; Wilcox GL
Eur J Pharmacol; 1991 Feb; 193(2):209-15. PubMed ID: 1710992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
